Abstract
Introduction
Comparative effectiveness research has been proposed as a potential avenue to identify, evaluate, and provide effective, safe, and cost-effective health care on the basis of informed and evidence-based decisions.(1) When comparing alternative health care options, it is essential to identify and combine the best available evidence on treatment effects, healthrelated preferences (utilities), resource use, and costs.(2) Nevertheless, the evidence could be absent or uncertain due to the limitations and weaknesses of the available studies. A costeffectiveness analysis that is based on such evidence is uncertain, and thus, any decision based on this analysis will also be uncertain.(3) Decision uncertainty is associated with risk because making the wrong decision could lead to costly consequences for the health care system (e.g., adopting suboptimal treatment). Acquiring additional information could reduce uncertainty and better inform decisions; however, there is a cost for obtaining further evidence in terms of the direct costs of conducting research and the opportunity cost of delaying the decision awaiting research results. (3, 4) In addition, under limited budgets, the money spent on a specific research study could be spent on health care or on other competing research proposals. Therefore, it is recommended to assess the need and value of additional research before making decisions. (5, 6) Value of information analysis has been proposed to aid decision makers decide simultaneously on the adoption of new technologies and the need for further research.
Various value of information methods have been developed and successfully applied to inform whether there is sufficient evidence to support new technologies, optimally designing research studies and setting research priorities. (7, 8) The majority of the published papers on value of information analysis are methodological. (7) Even in the applied papers, the topic is often presented with complexity rendering this approach difficult to grasp by non-specialist. Thus, there is a need to present the principles and advantages of value of information analysis to decision makers, researchers, and practitioners in a succinct but comprehensive manner. The objective of this paper is to review value of information principles and applications in health care.
Scope
The first section of this paper describes the principles of value of information analysis, and the second section reviews the applications of value of information in health care. The general approach is to identify the relevant literature to inform this review searching various databases including PubMed, Medline, CINAHL and the National Health Service Economic Evaluation Database for value of information articles published from January 2003 to January 2013. Search terms included: 'value of information', 'value of perfect information', 'value of sampling information', and 'value of perfect parameter information'. These terms were searched in combination with the terms 'decision making', 'trial design' and 'research prioritization'. A narrative approach is used to summarize and present the principles and applications of value of information from the reviewed articles.
Principles of Value of Information Analysis
Value of information analysis provides an analytic framework to quantitatively estimate the value of acquiring additional evidence to inform a decision problem. 4. What is the optimal research study design?
5. What priority should this research study take?
Is additional research required?
To know whether additional research is required, it is essential to consider the expected cost of the consequences of making a wrong decision (i.e., the cost of uncertainty).(3) High expected cost of uncertainty indicates a need for acquiring further information before making a decision. The expected cost of uncertainty is determined by two factors: 1) the probability that a decision is wrong, and 2) the consequences of this potentially wrong decision. (9) To explain how the cost of uncertainty is estimated, a simplified hypothetical example is presented for two treatment interventions (A and B) modeled in a cost-effectiveness analysis.
The uncertainty in the results of the cost-effectiveness analysis is characterized by presenting the expected net benefit estimates (i.e., effects measured in monetary terms minus costs) for each intervention. In this example, the model is calculated five times to reflect various possible values of the model parameters ( Multiplying per-patient EVPI by the population of patients expected to benefit from the evaluated intervention over a period of time gives the population EVPI which represents the maximum potential value (i.e., upper bound) of additional research. (8, 9 ) If the population EVPI appears to exceed the cost of additional research study, then this study is potentially worthwhile and further assessment is required to inform its optimal design. (9, 11) Nevertheless, it has been argued that population EVPI is neither necessary nor sufficient to inform whether additional research is worthwhile because it is impossible to estimate the expected cost of research without knowing the specific research study design (e.g., sample
size, follow-up time). (8) However, calculating population EVPI is relatively simple and considered a continuation step to uncertainty assessment in cost-effectiveness analyses. When the population EVPI approaches zero it is unlikely that the value of additional research will exceed its cost and there will be no need to undertake further value of information analyses.(12)
What type of research?
If further research appears potentially worthwhile based on the population EVPI, it would be useful to identify the particular aspects of a decision problem that are worth studying to resolve the uncertainty surrounding them. (11) This could be achieved by estimating the expected value of information for certain input parameters in a given economic evaluation, often referred to as the partial EVPI or the expected value of perfect parameter information (EVPPI). (3) EVPPI is defined as the difference between the expected value of a decision made with perfect information on the selected parameters and the decision made based on current information.(11) EVPPI serves as a measure of the sensitivity of the economic evaluation to the uncertainty in its different input parameters.(3, 11) A parameter with a higher EVPPI is more uncertain and further research can be designed and focused to get more precise estimate of its value. Importantly, the nature of the uncertain parameter(s)
would inform the type and possibly the cost of the additional research study needed (e.g. randomized controlled or observational).(3, 11)
Do the benefits of research exceed the costs?
When the benefits of additional research study in reducing decision uncertainty exceeds its total cost, then this study is worthwhile. EVPI and EVPPI measure the expected value of additional research providing perfect information to resolve uncertainty of all parameters or specific parameters.(10) However, acquiring perfect information requires a very large research sample (i.e., infinite sample size) which is not practical. In reality, it is only possible to reduce uncertainty with additional information from a research study of a finite sample size. (5) The expected value of sample information (EVSI) estimates the expected value of reducing the uncertainty by a given research study with a specific sample size within a particular study design. (8) This can be calculated for all effect and cost parameters (i.e., total EVSI) or for the parameter(s) of interest (i.e., partial EVSI). (13) Population EVSI is calculated by multiplying the per-patient EVSI by the size of the population to whom information from the trial is valuable. (8) The expected total cost of a research study includes three components: 1) fixed cost (e.g., set-up cost, salaries), 2) variable cost per patient, and 3) an opportunity cost for those patients who receive the inferior intervention while the study is underway. (6) The total cost commonly takes a societal perspective; however, this cost may also be from the perspective of the sponsor of the study. The difference between the population EVSI for a specific study design and its expected total cost is the expected net benefit of sampling (ENBS). (8) A positive ENBS indicates that the research study is worthwhile. Conversely, when the ENBS is negative, it would be irrational to conduct further research because the expected costs of the study exceed its expected benefits, and in this case, the current available evidence is sufficient for decision making. (14) The EVSI and the ENBS are the preferred measures of value of information because they are sufficient to inform whether a specific research study is potentially worthwhile.(8)
What is the optimal research study design?
The sample sizes of clinical trials are usually calculated based on type I and II error, and the minimum clinically important difference. (15) The value of information framework provides an alternative to the standard hypothesis testing approach which relies on arbitrary chosen error probabilities where type I and type II error receive the same weight (e.g., 5%
and 20% respectively) regardless of the consequences of making an error.(10, 16) Figure 1 shows the population EVSI across a number of sample sizes for a future research study. As the sample size increases and more uncertainty resolved the calculated population EVSI converges to the population EVPI (i.e., upper bound). Deducting the expected total cost from the EVSI results in the ENBS curve which, in this example, is positive for a wide range of sample sizes; however, the ENBS is at maximum when the sample size is 250 patients in each arm which represents the optimal sample size. Table 2 where five research proposals are being compared.
Nevertheless, it has been argued that the proposal with the highest ENBS may not necessarily provide the highest return on investment (i.e., ENBS divided by the expected total cost of research).(8)
<<TABLE 2 GOES HERE>>

Value of Information Applications in Health Care
Value of information analysis is increasingly applied in health care to inform decisions, optimize trial design and prioritize research. 
Informing decisions
The most explicit use of value of information methods to inform decisions is by the National Institute for Health and Clinical Excellence (NICE) in England. Claxton and colleagues (9) have developed a value of information based framework for NICE to inform the following decision options:
1. Approve based on existing information. exceeds the sponsor's (industry), then current evidence is sufficient since any price between the thresholds is acceptable to both. However, if the decision maker's threshold price is lower than the company's, then no price is acceptable to both and the company's optimal strategy is to conduct additional research.(25)
Optimizing trial design
The use of the value of information methods in optimizing trial design remains limited and most applications have been restricted to the estimation of optimal sample size, and mainly in two-arm randomized trials. (14, 26, 27) For the policy aspect, the main issue is that the decisions to adopt technologies and to conduct research are usually separate. (11) Claxton et al. noted this point in their first pilot study on value of information: "The key problem seems to be the policy environment where accountability and transparency for research prioritization and commissioning lags behind adoption and reimbursement decisions, and where there appears to be a separate remit for reimbursement and research decisions".(11) Furthermore, the approach is relatively new and it will be some time before its value is realized by decision makers. Therefore, for the value of information analysis to be more incorporated into decision making frameworks, there is a need to create more awareness about the value of this approach and to align its methods with the needs of the decision making organizations.(7)
Conclusion
Value of information analysis is a systematic framework to measure decision uncertainty and assess whether there is sufficient evidence to support new technologies.
Various value of information methods have been developed to inform decision making, optimally designing research studies and setting research priorities. The application of VOI analysis in health care is increasing but remains limited due to conceptual, technical and policy challenges. Therefore, there is a need to create more awareness about this approach, simplify its current methods, and align them with the needs of the different jurisdictions in order for this approach to be incorporated into decision frameworks. Figure 1: Optimal sample size determination using value of information methods EVSI = expected value of sample information; ENBS = expected net benefit of sampling 
